Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V9NE
|
||||
| Former ID |
DNC002674
|
||||
| Drug Name |
Tanaproget
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Estrogen deficiency [ICD10:E28.39] | Investigative | [542440] | ||
| Formula |
C16H15N3OS
|
||||
| InChI |
InChI=1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21)
|
||||
| InChIKey |
PYVFWTPEBMRKSR-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Progesterone receptor | Target Info | Inhibitor | [551374] | |
| KEGG Pathway | Oocyte meiosis | ||||
| Progesterone-mediated oocyte maturation | |||||
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.